News

Researchers detailed their systematic review protocol which will aim to evaluate the effects of bortezomib on the overall survival, progression-free survival, overall response rate, time to next treatment, health-related quality of life,...

Findings from a recent real-world analysis on patients with mantle cell lymphoma revealed high attrition rates, as well as a need for more effective treatment options for those in earlier lines of therapy.

Researchers detail current first-line treatment options for the management of metastatic renal cell carcinoma and propose a framework for optimal treatment selection.

A panel of expert members of the American Society of Clinical Oncology used informal consensus to develop updated recommendations on the appropriate use of breast cancer biomarker assay results to guide decisions about using adjuvant...

Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.

A recent article discusses oncology-specific considerations when assessing elements of value, offering some background on the nature and development of quality-adjusted life-years as a part of cost-effectiveness analyses and some of their key...

Findings from a recent study identified a need for systematic implementation of oncology financial navigation to address patient and caregiver financial hardship.

Researchers established a multidisciplinary lung cancer clinic in a large, community-based healthcare system and conducted a prospective, comparative-effectiveness study to evaluate patients’ experiences with and outcomes of clinic care.

Study findings suggest that there is a need for tailored patient and oncologist information and education on trastuzumab biosimilars, as well as improved health care communication regarding switching.

PEG biosimilars may be able to optimize febrile neutropenia management among patients with intermediate-to-high risk febrile neutropenia while minimizing costs.